More on failures of cobalamin assays in pernicious anemia [4]

New England Journal of Medicine

Volumn 367, Issue 16, 2012, Pages 1570-

  Devalia, Vinod ^a  

^a PRINCESS OF WALES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; HOLOTRANSCOBALAMIN; INTRINSIC FACTOR; UNCLASSIFIED DRUG; CYANOCOBALAMIN;

ASSAY; COMPETITIVE BINDING LUMINESCENCE ASSAY; DIAGNOSTIC ERROR; HUMAN; LETTER; LUMINESCENCE; PERNICIOUS ANEMIA; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; BLOOD; LABORATORY DIAGNOSIS; NOTE;

ANEMIA, PERNICIOUS; FALSE NEGATIVE REACTIONS; HUMANS; VITAMIN B 12;

EID: 84867590896     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1210169     Document Type: Letter

References (4)

1. Devalia V. Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay. BMJ 2006;333:385-6.
2. Heil SG, de Jonge R, de Rotte MC, et al. Screening for metabolic vitamin B12 deficiency by holotranscobalamin in patients suspected of vitamin B12 deficiency: a multicentre study. Ann Clin Biochem 2012;49:184-9.
3. Nexo E, Hoffmann-Lücke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr 2011;94:359S-365S.
4. Carmel R. Holotranscobalamin: not ready for prime time. Clin Chem 2012;58:643-5.